Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells

Published:2015-11-05 Issue:1 Volume:65 Page:1-11
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Müller Philipp,Rothschild Sacha I.,Arnold Walter,Hirschmann Petra,Horvath Lukas,Bubendorf Lukas,Savic Spasenija,Zippelius Alfred

Funder

Schweizerische Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CH)

Wilhelm Sander-Stiftung (DE)

Krebsliga Beider Basel (CH)

Huggenberger-Bischoff Foundation for Cancer Research

Research Fonds of the University Basel

Akademische Gesellschaft Basel

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-015-1768-3.pdf

Reference58 articles.

1. Khong HT, Restifo NP (2002) Natural selection of tumor variants in the generation of “tumor escape” phenotypes. Nat Immunol 3:999–1005. doi: 10.1038/ni1102-999

2. Lin A, Schildknecht A, Nguyen LT, Ohashi PS (2010) Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth. Immunol Lett 127:77–84. doi: 10.1016/j.imlet.2009.09.003

3. Chen JJ, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, Tsai MF, Chen CH, Yang PC (2005) Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 23:953–964. doi: 10.1200/JCO.2005.12.172

4. Loose D, Van de Wiele C (2009) The immune system and cancer. Cancer Biother Radiopharm 24:369–376. doi: 10.1089/cbr.2008.0593

5. Audia S, Nicolas A, Cathelin D et al (2007) Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes. Clin Exp Immunol 150:523–530. doi: 10.1111/j.1365-2249.2007.03521.x

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor infiltrating lymphocytes in gastric cancer: Unraveling complex interactions for precision medicine;World Journal of Clinical Oncology;2024-04-24

2. Prognostic value of CD8+T cells related genes and exhaustion regulation of Notch signaling pathway in hepatocellular carcinoma;Frontiers in Immunology;2024-04-08

3. Tumor Inflammatory Microenvironment in Lung Cancer: Heterogeneity and Implications;Handbook of Oncobiology: From Basic to Clinical Sciences;2024

4. Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma;Cancers;2023-11-14

5. Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancer;OncoImmunology;2023-05-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3